Actively Recruiting
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Led by Roswell Park Cancer Institute · Updated on 2026-04-06
30
Participants Needed
1
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This clinical trial tests how well current daily smoking adults can identify flavors of cigarettes. Menthol cigarettes account for 31 percent of cigarettes sold in the United States. Flavors such as menthol play an important role in the start and continued use of tobacco products. Two ways users experience flavor is through smell and taste. Menthol has cooling and numbing properties that can increase perceptions of smoothness and reduce the perceived harshness of smoke. Menthol adds a taste and aroma commonly described as "minty". The effect of menthol flavoring on smoking behavior has been studied. Use of menthol cigarettes has been associated with greater nicotine dependence and is associated with both fewer quit attempts and lower odds of quit success. In 2022, the Food and Drug Administration proposed to restrict the use of menthol as a flavor in cigarettes. Menthol has already been banned in Canada, the United Kingdom and the European Union. In late 2022, a restriction on all flavored tobacco products went into effect in California (CA), prompting the tobacco industry to introduce substitute products that did not contain menthol. It is important to find out whether New York (NY) adult smokers who smoke menthol cigarettes can identify and characterize flavors in the same cigarette brand as sold in NY versus CA following the ban of menthol cigarettes in 2022.
CONDITIONS
Official Title
Sensory Tests of Cigarettes for Identification of Flavors in Current Daily Smoking Adults
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 21-55 years old
- Current daily smoker of factory-made menthol cigarettes
- General good health as self-reported
- Completion of Brief Smell Identification Test with no smell deficits
You will not qualify if you...
- Daily use of other tobacco products such as e-cigarettes, cigars, or smokeless tobacco
- Known allergies to mint or menthol
- Self-reported problems with smell or taste
- Pregnant or nursing
- Use of medications that affect sense of smell
- Positive COVID-19 diagnosis within 10 days before enrollment
- Current upper respiratory infection or sinus congestion
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Roswell Park Cancer Institute
Buffalo, New York, United States, 14263
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
BASIC_SCIENCE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here